Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS
12019 / Pixabay

Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS

According to a story from BioPortfolio, the immunotherapy drug Kymriah, a type of CAR-T cell therapy, will be funded by NHS England for the treatment of patients with acute lymphoblastic…

Continue Reading Immunotherapy Treatment for Acute Lymphoblastic Leukemia to be Covered on England’s NHS